Laura Devlin (@elldev33) header
Laura Devlin (@elldev33) profile picture

Gardener, Herbalism enthusiast. Pharmacist Passionate about deprescribing

Joined February 2011
Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)Photo by Laura Devlin (@elldev33)
Laura Devlin retweeted
"I don’t just think antidepressants are overprescribed, I’m not convinced they’re useful at all. Antidepressants don’t rectify a chemical imbalance or any other biological process, as people were led to believe; they numb emotions" "The question is, is this useful, and how harmful are they?" 👇 telegraph.co.uk/health-fitne…
43
111
26
360
47,554
Laura Devlin retweeted
We need to talk more about late onset/cumulative drug effects for medications more. Not the effects you get when you first start taking them. I mean the ones that creep up on people bit by bit slowly diminishing their health and quality of life. Where is the informed consent for this?
9
12
56
1,287
Laura Devlin retweeted
They need our help. Now more than ever. Bring the California refugees home.
655
3,931
422
19,143
1,019,330
As I’m winding down my 4th year since tapering off of clonazepam, I can confirm that BIND is a long-lasting challenge. Light and sound sensitivity, balance /proprioception problems, ridiculous muscle tightness, and strong waves of anxiety persist. It is a very slow recovery.
Jordan Peterson developed this condition eight years ago. He is still recovering from it today. And there’s a good chance your doctor has never heard of it. It’s called benzodiazepine-induced neurological dysfunction, BIND for short: a late-onset toxicity from drugs like Klonopin, Xanax, and Valium. The reason most doctors don’t know it exists isn’t negligence. It’s timing. This condition has only been described in the medical literature over roughly the last five years, and most prescribers’ knowledge of benzodiazepines was set decades before that. So patients show up describing it and get blank stares, or worse, new diagnoses. Here’s what it actually looks like, from a research team out of Colorado and Vanderbilt who studied these patients. Ninety percent experience nervousness, anxiety, and fear, often extreme, running through the entire day. Sleep disturbances. Difficulty focusing. Low energy. And a strange hypersensitivity to light, sound, and a whole range of ordinary stimuli, as if the nervous system’s volume knob is stuck on maximum. And the detail that separates BIND from everything else: these symptoms can continue for years after the medication is stopped. That’s what makes it so disorienting for patients and so invisible to doctors. “The drug is out of your system” is true. The injury it left behind is the condition. If you’ve been on a benzodiazepine long term and this list reads like your life, you’re not imagining it, and you’re not rare. The literature finally exists. Bring it to your doctor. If you’re looking to safely taper off a psychiatric medication, comment TAPER and I’ll send you my free tapering guide. It’s the exact protocol we use with our patients at TaperClinic.
1
1
44
Laura Devlin retweeted
“SSRIs are whole-body drugs whose full effects we still don’t understand. Even Prozac’s label admits its exact mechanism is unknown. And no, it’s not correcting a serotonin deficiency. That’s marketing.” 🔥
One shitty Iranian trial of 40 kids inflated Prozac’s benefit in two major meta-analyses. Remove the trial and the benefit halves. Think of this the next time your doctor condescends to you about “the Science.” This is the science. Cochrane’s 2021 review found Prozac offered just 2.84 CDRS-R points over placebo (96-point range): “small and unimportant.” Kirsch’s adult analysis found 1.8 HAM-D points over placebo. That’s 40% below the NICE benchmark for a clinically meaningful benefit. These are the numbers behind all that hubris. SSRIs are whole-body drugs whose full effects we still don’t understand. Even Prozac’s label admits its exact mechanism is unknown. And no, it’s not correcting a serotonin deficiency. That’s marketing. Lilly’s own correspondence reveals instructions to code suicide attempts as “overdoses” and suicidal thoughts as “depression.” Courts have found antidepressants responsible for egregious homicides and murder-suicides, even at normal prescribed doses. Severe sexual side effects can persist for decades after stopping these drugs. For some people, getting off means years of careful hyperbolic tapering, down to fractions of a milligram. And we’re giving these drugs to children like they’re Tylenol. This has to stop.
14
2
59
1,182
This is certainly the most consequential paper published in child and adolescent psychiatry for the last few years. It shows that the meta-analyses that current child psychiatry guidelines rely on to recommend fluoxetine for depression were skewed by an unbelievable trial (n=40) in Iran which found an effect 15 times larger than the average. When this trial is removed all meta-analyses find the same as a recent Cochrane analysis which found 'small and unimportant differences.' The flawed meta-analyses by Zhou and @cipriani in the @TheLancet and Lancet Psychiatry need to be corrected. And guideline committees need to update their guidance in the context of the harms of these drugs including withdrawal effects, sexual effects and agitation/akathisia and suicidality in a minority of youths exposed to them. Link below
28
228
32
733
74,553
In an analysis of drug withdrawal to the FDA adverse effects database here were the signals for the 20 drugs with strongest risk of withdrawal. Paroxetine, duloxetine and venlafaxine where in the top 20. Paroxetine was no. 4, above several opioids.
39
81
14
307
49,249
Laura Devlin retweeted
My dad died Wednesday at 91. It’s never long enough. In his final hours, we took him from the hospital back to memory care so they could be together. Two months shy of 67 years of marriage.
1,830
4,637
423
182,613
7,653,692
Laura Devlin retweeted
When you take an SSRI you are not correcting a chemical imbalance... you are inducing one. Be aware of those consequences. They are not benign.
46
173
14
1,055
26,299
The Australian Journal of General Practice from @RACGP published out letter today titled 'The importance of minimising long-term antidepressant use'. Given there is no robust evidence of benefit (discontinuation trials are confounded and not reliable) but evidence of harm we should be aiming to minimise long term use of these medications. Link below.
5
34
1
84
2,602
A patient was admit to the ICU where I worked in 2019 Their diagnosis? “Zoloft withdrawal” There is so much we haven’t been told about these medications. It’s time for thorough research into what happens in SSRI withdrawal. Clearly, autonomic dysfunction is occurring
I tapered off 50mg of sertraline and had an acute autonomic collapse a few days after my last dose. I’d had brain zaps, dizziness, gut pain, loose bowels, and anxiety etc while tapering down. One morning, sitting on the back deck, I got sudden & severe overheating & abdo pain, dizzy, couldn’t stand up. Passed out and came to on the bathroom floor, surrounded by what looked like a month’s worth of colon contents. BP dropped to 85/40, heart rate shot up ~160; this was after I came to, no idea what they were when I passed out. My body felt like it was cooking from the inside out, and I remember thinking I was actually going to self combust. I could barely move or speak, my body felt like heavy lead, and I slept for hours after. Lucky my husband was there to catch my fall or I probably would have had a head injury too. If he hadn’t been there to help me I could have actually died on the outside deck. What followed was months of inexplicable inner dread and terror, intrusive & unrelenting suicidal and other dark thoughts, insomnia, nightmares, night terrors & waking up in a panic, sudden anxiety surges, restlessness, restless legs, terrible brain fog and fatigue, PSSD, and a completely trashed gastric system, plus other symptoms. I’d never experienced these things in my life, only when I stopped the drug. I clearly didn’t taper slow enough. About 2 years total to get to about 95% normal. These drugs break people, they are dangerous. #SSRI #MentalHealth #PrescribedHarm #PSSD #Psychiatry #Antidepressants
17
34
3
224
11,445
Laura Devlin retweeted
When I was thirteen, my best friend died and I reacted in myriad unhealthy ways, so my parents took me to a psychiatrist and I was disgnosed with depression and prescribed Zoloft, an anti-depressant. But I wasn’t clinically depressed; I was sad, and I had a good reason to be. So, I think a good thing for a lot of young people to hear is that being sad is okay because sometimes life sucks, but that doesn’t mean you’re depressed or something is wrong with you. Your emotions might just be working the way they’re supposed to.
107
272
23
4,270
113,258
Replying to @markhoro
Having served 9 years as the Consumer Rep on FDA’s Psychopharmacologic Drugs Advisory Committee, I saw firsthand how surrogate endpoints, prior failed studies, “breakthrough” designations and fast-tracking for “unmet need” can lower the hurdle for getting drugs to market. Consumers and doctors need to better understand what “FDA approved” actually means, including what remains unknown. It has been an eye opening experience.
4
6
1
30
2,248
Agree with Prof Ostacher here. The FDA is not fit for purpose when it lets a drug onto the market with 10 out of 12 failed trials (2 barely positive) and overall no effect. This means patients will be exposed to a host of harms for no benefit. Will this approval be reversed ? Who is responsible at the FDA for this approval?
Replying to @FDA
@US_FDA really needs to change its rules. We don't need drugs that fail in multiple trials only to succeed in two. Paroxetine (Paxil) is another drug that probably should not have made it to market, but alas... @markhoro
6
20
3
80
10,052
“My entire brain development happened under the influence of psychiatric drugs.” “No one told my parents that the long-term effects of antidepressants on the developing brain had never been properly studied.”
Danielle Gansky has lived nearly her entire life on psychiatric drugs. And she’s just one of thousands who feel like part of who they are is missing because of it. “My entire brain development happened under the influence of psychiatric drugs.” “No one told my parents that the long-term effects of antidepressants on the developing brain had never been properly studied.” “Essentially, we’re conducting a mass experiment on children’s developing brains with little understanding of the long-term consequences.” “I often wonder a lot who I might have been without them.” “I don’t know who I am underneath it all.” “Sometimes that fills me with a lot of grief to be like, ‘What have I missed out on?’” @DanielleGansky @Realalexclark
1
2
60
Patients often wonder what they can do to help bring safer deprescribing. All should report their adverse drug reactions and problems deprescribing to FDA via Medwatch Reporting. FDA is taking them seriously, reading them, and contacting patients. See link in comments below.
3
8
1
34
918
“50 percent dose reduction for CYP2C19 poor metabolizers” We really need to test gene snps BEFORE prescribing. If you’re a poor metabolizer and take a “low” dose, you could feel horribly activated and potentially suicidal within hours to days. We need to do better.
She took 25mg and stayed awake 48 straight hours. Her psychiatrist stopped the drug because of it. That looks like a metabolic issue. It also looks like activation syndrome. And the exposure argument doesn't hold. SERT occupancy saturates around 1.9 ng/mL. It's hyperbolic, not linear. Twenty-five milligrams over a few days puts you near the plateau. We see patients become suicidal within days of starting this drug. Activation comes early. That's why the boxed warning covers initiation and dose change. On the FDA point. Label changes happen when a sponsor files for one, and sertraline has been generic for years. Nobody has any reason to fund a labeling revision for a drug they don't own. The science on CYP2C19 and sertraline exposure exists. The label just doesn't reflect it. And your own bodies don't agree. CPIC recommends a 50 percent dose reduction for CYP2C19 poor metabolizers. The Dutch group says genotyping is potentially beneficial. FDA says nothing. "Not standard of care" describes what American prescribers do. It isn't a finding about her ability to tolerate a drug. Standard of care shifts only after someone studies the question- thoroughly.
41
Laura Devlin retweeted
The FDA approved gepirone extended release for #Depression based on 2 positive trials despite 11 negative or inconclusive trials, highlighting the agency's use of regulatory flexibility and trial-level statistical significance. ja.ma/3SmbQIX
13
2
30
5,057
Thoughtful attempt here to understand what might be the molecular mechanisms of protracted withdrawal states (recognised for all psychiatric drug classes): "Treatment discontinuation is not simply a pharmacological absence. It is an active neuroadaptive state shaped by pharmacodynamic rebound, allostatic counterregulation, and gene-regulatory carryover that can persist well beyond drug clearance" Sad that some other clinicians/academics want to pretend that because they don't understand what is going on that it must not be going on....and must be something wrong with the patient. nature.com/articles/s41386-0…
12
34
1
91
4,311